Article

Cardiovascular Medications Not Prescribed Equally Among Men and Women Study Says

Some cardiovascular medications are prescribed to women less often than men according to a study published today in the Journal of the American Heart Association.

Some cardiovascular medications are prescribed to women less often than men according to a study published today in the Journal of the American Heart Association.

Previous research found that female hearty attack survivors were less likely to be given prescriptions for recommended medications then their male counterparts in the hospital.  This metanalysis examines whether preventative medications such as statins, aspirin, ACE inhibitors and diuretics are prescribed equally across the genders prior to heart attack.

The results showed that women received:
• 19% fewer aspirin prescriptions than men;
• 10% fewer statin prescriptions than men; and
• 15% fewer ACE-inhibitor prescriptions than men. 
• 27% more prescriptions for diuretics.

"Additional efforts need to be taken to ensure that everyone, women and men, who should receive cardiovascular medications are actually prescribed these medications," said lead study author Sanne Peters, Ph.D., research fellow in epidemiology at the George Institute for Global Health at the University of Oxford in the United Kingdom and associate professor at the University Medical Center Utrecht in the Netherlands. "We also need to reduce the persistent treatment gaps between women and men."

Related Videos
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.